Page 4 - Holliday Communications Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Harrow Sells Non-Ophthalmic Compounding Business

Harrow Sells Non-Ophthalmic Compounding Business
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJamie webbMarkl baumDeb hollidayRevelation pharma corporationInnovation compounding pharmacyHolliday communications incWall streetChief executiveMelt pharmaceuticalsNorth americanOsceola capitalInvestor relations

Sintetica SA: Harrow Announces U S FDA Approval of IHEEZO (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia

IHEEZO Represents the First Approved Use in the U.S. Ophthalmic Market of Chloroprocaine Hydrochloride and the First Branded Ocular Anesthetic Approved for the U.S. Ophthalmic Market in Nearly

San diegoUnited statesSwitzerland generalKostenloser wertpapierhandelJamie webbMarkl baumNicola caronzoloDaniele fontanaDeb hollidayExchange commissionAmerican society of cataractOld international pharmaceutical company sinteticaInstitute for safe medication practicesDrug administrationHolliday communications incFirst approved use

Harrow Announces U S FDA Approval of IHEEZO™ (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia

/PRNewswire/ Harrow (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative.

San diegoUnited statesSwitzerland generalJamie webbMarkl baumNicola caronzoloDaniele fontanaDeb hollidayAmerican society of cataractInstitute for safe medication practicesDrug administrationHolliday communications incApproved useChloroprocaine hydrochlorideFirst branded ocular anesthetic approvedCanadian markets from

Harrow Announces U S FDA Approval of IHEEZO (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia

IHEEZO Represents the First Approved Use in the U.S. Ophthalmic Market of Chloroprocaine Hydrochloride and the First Branded Ocular Anesthetic Approved for the U.S. Ophthalmic Market in Nearly 14 Years

San diegoUnited statesSwitzerland generalKostenloser wertpapierhandelJamie webbMarkl baumNicola caronzoloDaniele fontanaDeb hollidayExchange commissionAmerican society of cataractOld international pharmaceutical company sinteticaInstitute for safe medication practicesDrug administrationHolliday communications incFirst approved use

Harrow Health (HROW) Granted FDA Approval of IHEEZO

Harrow Health (HROW) Granted FDA Approval of IHEEZO
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesSwitzerland generalJamie webbMarkl baumNicola caronzoloDaniele fontanaDeb hollidayExchange commissionAmerican society of cataractInstitute for safe medication practicesDrug administrationHolliday communications incWall streetOrange book listedNew drug application